Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broad chest aerosol in recovery-phase ischemic stroke
ChiCTR2200067018Phase 3Not yet recruiting
- Sponsor
- Hangzhou Third People's Hospital
- Start
- Jan 2023
- Countries
- 1
01
Overview
Phase 3 trial of broad chest aerosol in ischemic stroke (2 arms), sponsored by Hangzhou Third People's Hospital. Primary endpoints: Magnetic resonance imaging of the skull, Activities of daily living rating scale and 4 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
broad chest aerosol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200067018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067018.